BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Alcohol
,
Cisplatin
,
rs2230926
,
PBX1
,
Coagulation
,
Lung cancer
,
Intestine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
dihydroethidium
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
A Plate Reader-Based Measurement of the Cellular ROS Production Using Dihydroethidium and MitoSOX.
A novel flow cytometry assay using dihydroethidium as redox-sensitive probe reveals NADPH oxidase-de…
Live-Cell Imaging of Mitochondrial Redox State in Yeast Cells.
Analysis of kinetics of dihydroethidium fluorescence with superoxide using xanthine oxidase and hypo…
Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-Bromopyruvate.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of the Effect of Beta-3 Adrenergic Receptor Agonists on Oxidative Stress and Signalling Pathwa…
Cardiovascular Outcomes of Low Testosterone
Liraglutide and Cardio-Metabolic Risk Markers
Risk of Oxygen During Cardiac Surgery Trial
Impact of Pumps on Internal Thoracic Arteries (IPITA)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ